Table 6.
Type of Nanocarrier, Form and Size (nm) | Type of Disease | Outcomes | References |
---|---|---|---|
Globular liposomes 25–205 |
Breast, colorectal and lung cancer Melanoma Renal ischemia Malaria |
High curcumin solubility, stability and tissue distribution. Increased anti tumor and anti angiogenesis effect. Anti malarial effect |
[125,126,127,128,129,130] |
Spherical micelles 10–100 |
Lung, colorectal and breast cancer | High curcumin solubility, bioavailability. Anti oxidative and anti tumor effect. |
[131,132,133,134] |
Cyclic cyclodextrins 150–500 |
Bowel disease Breast, lung, pancreas and prostate cancer |
High curcumin solubility, bioavailability. Enhanced anti proliferative effect. Anti cancer and anti inflammatory effect. |
[135,136,137] |
Globular dendrimers 15–150 |
Breast and colon cancer | High curcumin stability. Enhanced anti proliferative and anti cancer effect. |
[138,139] |
Cross-linked polymer network nanogel 10–200 |
Melanoma Breast, pancreas, colorectal and skin cancer |
High curcumin bioavailability, half-life and controlled release. Anti cancer effect. |
[140,141,142] |
Globular gold nanoparticles 200–250 |
Prostate and colorectal cancer. | High curcumin stability. Enhanced anti proliferative and anti cancer effect. |
[143,144] |
Spherical solid lipid nanoparticles 50–1000 |
Cerebral ischemia Colitis Allergy Breast cancer |
Prolonged blood circulation Anti inflammatory effect Improved brain delivery |
[145,146,147] |